Africa Healthcare Network (AHN) has secured $20 million in equity and debt funding from a consortium of investors led by two African institutions, Africa50 and AfricInvest. The other institution is Tokyo-based Ohara Pharmaceutical Co Ltd.
The funding will be used to bolster AHN’s accelerated Pan-African growth and expansion as well as address significant gaps in the availability of high quality, affordable renal care across the continent.
For more information, please see https://www.theeastafrican.co.ke/tea/business/africa-healthcare-network-secures-20m-for-expansion-4442040
